Subscribe to the Vault RSS Feed.

Posts Tagged:

The Rise of Supersalaries, Income Inequality, and Thomas Piketty's 'Capital'

I live in Brooklyn, and this past weekend, at my local independent bookstore, where the titles that typically move are those written by the many novelists who live in the outer borough, front and center in the store window and on the checkout counter was the new, Bible-thick, nonfiction title Capital in the Twenty-First Century, by French economist Thomas Piketty. Capital, if you haven't heard, has been receiving a ridiculous amount of praise. Read More >

History of the Male-Female Salary Gap: A 95-Year-Old Problem

Last year, the Equal Pay Act signed by John F. Kennedy turned 50 years old. The Act was designed to create a society where women were as valued as men in the workforce and to remove barriers that caused discrimination. Because of that Act, when discussing equality in the workplace, 1963 is widely considered the beginning of establishing a fair playing field for women in the workforce. However, the problem was not a new one in the early '60s. Read More >

Which Law Firms are Cashing in on the Donald Sterling Scandal?

If you turned on a TV, opened a newspaper or used the Internet this past week, you probably heard about the latest scandal in the NBA. A recording of Los Angeles Clippers owner Donald Sterling making racist remarks to his (then ?) girlfriend was leaked to celebrity gossip website TMZ and subsequently blasted across all media outlets. Advertisers started dropping their sponsorship of the team faster than John Wall and there were rumblings of fan protests. Read More >

Should You Disclose Your Salary in an Interview?

A friend recently asked me for advice on dealing with a scenario that will be common to many job seekers: he was getting pretty deep into the recruitment process with a firm, but no-one had mentioned money. When, he wanted to know, was the right time to bring it up? And, given that he feels significantly underpaid in his current position, how could he avoid being lowballed this time out? Read More >

Who's Burning the Midnight Oil for Pfizer?

Following last week's flurry of pharma deal activity, on Monday Pfizer announced its intention to acquire British drug maker and serious competitor AstraZeneca. The potential $100 billion dollar acquisition would be one of the largest pharma deals in history, topping Pfizer's $90 billion purchase of Warner-Lambert in 2000. Among other reasons (such as the tax benefits of doing business outside the U.S.) AstraZeneca's vast portfolio of cancer drugs makes it an attractive purchase. Read More >

Face It, We’re Cubed

There's a very good chance that right now you're seated in a swiveling, ergonomic chair on wheels, staring at a computer screen, reading these digital words within three or four flimsy chest-high walls, just beyond which is another person who's seated in a swiveling, ergonomic chair on wheels, staring at a computer screen, reading other digital words within three or four flimsy chest-high walls, just beyond which is another person … and so on, and so on, and so on. Read More >

Congrats to the 2014 Top Ten Family Friendly Firms

Vault is pleased to recognize the 2014 Top 10 Family Friendly Firms as determined by Yale Law Women. Yale Law Women's Top Ten Family Friendly Firms Initiative surveys the policies of law firms ranking in Vault's Top 100. The survey evaluates factors such as the billiable hour requirement, part-time and flex-time options, parental leave policies and child care availability. The survey looks at law firm policies and their utilization by both male and female attorneys. Read More >

Pope Francis' First Year: The Next Great Harvard Business School Case Study?

If the Roman Catholic Church were a public company, its share price would have doubled in the past year and its CEO would now be in a strong position to ask the board for a raise. This is more or less what The Economist implied last week when it published an article called "The Francis Effect," comparing the Pope to great turnaround CEOs "such as IBM's Lou Gerstner, Fiat's Sergio Marchionne, and Apple's Steve Jobs. Read More >

Which Lawyers Are Lining Up for Botox?

OK, maybe not in the literal sense, but if you are an aspiring attorney interested in getting a piece of the pharma pie you can start salivating now. On Tuesday drug companies announced deals potentially worth a total of $74 billion, and the top law firms are all over that. Valeant Pharmaceuticals, a Canadian company, announced a $46 billion hostile bid for Botox-maker Allergan. The deal is backed by Valeant shareholder Pershing Square Capital Management, a private equity firm. Read More >

Deutsche Bank's $4 Billion Hangover, Part 2

Three years ago, just after the Deutsche Bank-owned Cosmopolitan hotel and casino opened in Las Vegas, I spoke with a Vegas insider about the German bank's big Sin City bet (you can read part of that conversation in a previous post here). Read More >

Popular Tags

Career Update Newsletter

Tips and tools to help you manage your ideal career.